Page 13 - 台灣肝癌醫學冬季會手冊-1222-V3_Neat

of primary biliary cirrhosis in T aiwan: A follow-up study up to 18 years. Liver Int 2008;28:1305-1313 (SCI, IF: 5.175) 3．

Hung HH, Chiou YY, Hsia CY, Su CW (corresponding author), Chou YH, Chiang JH, Huo TI, Huang YH, Su YH, Lin

HC, Lee SD, Wu JC. Survival rate are comparable following radiofrequency ablation or surgery in patients

with small hepatocellular carcinomas. Clin Gastroenterol Hepatol 2011;9:79-86 (SCI, IF: 8.549)

4． Su CW, L HJ, Chau GY, Hung HH, Wu JC, Hsia CY, Lui WY, Su YH, Wu CW, Lee SD. The effect of age on the

long-term prognosis of patients with hepatocellular carcinoma after resection surgery: A propensity matching

g

g

analysis. Arch Sur 2012; 147:137-144 (SCI, IF: 13.625) (Journal title changed to JAMA Sur since 2013)

5． Kao WY, Hwang CY, Chang YT, Su CW (corresponding author), Hou MC, Lin HC, Lee FY, Lee SD, Wu JC. Cancer

risk in patients with pyogenic liver abscess: a nationwide cohort study. Aliment Pharmacol Ther 2012;

36:467-476 (SCI, IF: 7.515)

6． Wu WC, Wu CY, Wang YJ, Hung HH, Yang HI, Kao WY, Su CW (corresponding author), Wu JC, Chan WL, Lin
HC, Lee FY, Lee SD. Updated threshold for serum alanine aminotransferase level in a large-scale population

study composed of 34346 subjects. Aliment Pharmacol Ther 2012;36:560-568 (SCI, IF: 7.515)
7． Kao WY, Su CW, Chiou YY, Chiu NC, Liu CA, Fang KC, Huo TI, Huang YH, Chang CC, Hou MC, Lin HC, Wu

JC. Hepatocellular carcinoma: Nomograms based on the albumin-bilirubin g to a of

radiofrequency ablation. Radiology 2017;285:670-680 (SCI, IF: 7.931) (The first two authors [Kao WY and Su CW] have
contributed equally to this work)
8． Chen PH, Hsieh WY, Su CW*(corresponding author), Hou MC*, Wang YP, Hsin IF, Yang TC, Liao WC, Lin HC, Lee FY,

Wu JC. Combination of albumin-bilirubin grade and platelet to predict compensated patient with hepatocellular carcinoma

w not require endoscopic screening for esophageal varices. Gastrointest Endosc 2018:88:230-9 (SCI, IF: 6.890)

Fang KC, Kao WY, Su CW*(corresponding author), Chen PC, Lee PC, Huang YH, Huo TI, Chang CC, Hou MC, Lin HC,
9． Wu JC*. The prognosis of single large hepatocellular carcinoma was distinct from the BCLC stage A or B: The role of
albumin-bilirubin grade. Liver Cancer 2018;7:335-58 (SCI, IF: 9.720)

Kao WY, Su CW*(corresponding author), Tan ECH*, Lee PC, Chen PH, Tang JH, Huang YH, Huo TI, Chang CC, Hou

10． MC, Lin HC, Wu JC. Proton pump inhibitors and risk of hepatocellular carcinoma in patients with chronic hepatitis B

or C. Hepatology 2019;69:1151-64 (SCI, IF: 14.679)
英文病例報告與評論 共 32 篇 Reviewer
of Journal 共 38 種 SCI 期刊